| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Atara Biotherapeutics, Inc. (ATRA) has 3 insiders with recent SEC Form 4 filings, including 1 buy and 13 sells. ATRA is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 1.32M | $13.97M | - | |
| CEO | 143.1K | $1.51M | - | |
| Other | 52.0K | $549.1K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| May 26, 2016 | Ciechanover Isaac E. | Chief Executive Officer | Sell | 7,200 | $17.69 | $127,368.00 | -1.0% | |
| May 18, 2016 | Gallagher Carol Giltner | Director | Sale+OE | 1,184 | $15.96 | $18,896.64 | -1.2% | |
| May 17, 2016 | Soffer Gad | Chief Operating Officer | Sale+OE | 5,427 | $15.91 | $86,343.57 | -3.8% | |
| May 16, 2016 | McGrath John | Chief Financial Officer | Sale+OE | 5,395 | $15.77 | $85,079.15 | -5.7% | |
| May 16, 2016 | Haqq Christopher | Chief Medical Officer | Sale+OE | 1,605 | $15.57 | $24,989.85 | -0.5% | |
| May 16, 2016 | Clark Mitchall G. | Chief R &Qa Officer | Sale+OE | 4,153 | $15.15 | $62,917.95 | -4.7% | |
| Apr 26, 2016 | Ciechanover Isaac E. | Chief Executive Officer | Sell | 1,300 | $20.12 | $26,159.00 | -0.2% | |
| Apr 12, 2016 | Ciechanover Isaac E. | Chief Executive Officer | Sell | 13,210 | $20.40 | $269,484.20 | -1.8% | |
| Apr 1, 2016 | Ciechanover Isaac E. | Chief Executive Officer | Sell | 1,190 | $20.03 | $23,838.60 | -0.2% | |
| Mar 17, 2016 | Dobmeier Eric | Director | Buy | 3,000 | $13.86 | $41,565.00 | +120.0% |